Another reason for getting ROW done and dusted is that it removes an issue that is surely taking a considerable amount of JP's (and others) valuable time.
If Neuren is to maximise the potential of NNZ-2591 they need to have their key human resources really focused on the options that will be possible if the current phase 2 trials are successful.
Hundreds of millions of dollars of shareholders investments (possibly more) might be at stake in just a few months time.
Share Price, page-5544
-
- There are more pages in this discussion • 6,325 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.76 |
Change
0.150(1.10%) |
Mkt cap ! $1.758B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $5.043M | 365.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $13.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.78 | 2834 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |